PHARMADANICA A/S: Financial statements 2023
CVR: 19056007
Source: annual report 2023, Danish Business Authority
01/04/2022 – 31/03/2023
PHARMADANICA A/S (CVR 19056007) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK -1,054,906 compared with DKK 475,959 the year before. Equity in the 2023 report amounted to DKK 17,501,052. The solvency ratio was 91.7%.
- Profit/Loss
- DKK -1,054,906
- Equity
- DKK 17,501,052
- Total Assets
- DKK 19,078,069
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | -1.1M | 17.5M | - |
| 2022 | - | - | 476K | 18.6M | - |
| 2021 | - | - | -792K | 18.1M | - |
| 2020 | - | - | -777K | 18.9M | - |
| 2019 | - | - | 3.3M | 19.6M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of May 25, 2023, Ilona Maureen Fischer has joined the board of directors of PHARMADANICA A/S.
As of May 25, 2023, Patricia Hec has left the board of directors of PHARMADANICA A/S.
As of February 1, 2023, Aymeric Erouart has left the board of directors of PHARMADANICA A/S.
About PHARMADANICA A/S
PHARMADANICA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named A/S PSE NR. 4943. The management consists of Jean-Marc Pierre Rene Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre Rene Leccia. The company is owned by MISSIONPHARMA A/S. The company has 3 employees (2004). In 2026, the company reported a net result of DKK 4,314,032 compared with DKK -339,647 the year before. Equity in the 2026 report amounted to DKK 20,960,385.